None listed
Conditions
Interventions
Dietary Supplement : On the screening visit, subject who voluntarily signs on the written informed consent is reviewed according to inclusion-exclusion criteria. After 2 weeks of run-in period, subjec
Sponsors
Seoul National University of Science and Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Subject who voluntarily agrees to participate and subjects and their parents (or legal representatives) sign in informed consent form 2) The ages of between 4 and 65 with intermittent or persistent symptoms of atopic dermatitis for more than 6 months
Exclusion criteria
Exclusion criteria: 1) Subjects who have systemic diseases such as skin diseases except for atopic dermatitis, immunodeficiency, autoimmune diseases, cancer, etc. 2) Use of systemic antibiotics, corticosteroids, or immunosuppressants related to atopic dermatitis within 1 month of the first visit 3) Use of medication related atopic dermatitis such as antihistamines, herbal medicines, or health functional foods within 1 month of the first visit 4) Presence of received phototherapy within 1 month of the first visit 5) History of hypersensitivity including ingredients (propolis, honey) or pollen in the placebo/test material, or severe food allergic reactions 6) Subjects who plan to participate in another clinical trial during current participation 7) Participation in another clinical trial within 1 month of the first visit 8) Subjects who, in the investigator's judgment, have a condition that would not allow to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Markers of atopic dermatitis | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse event, vital signs | — |
Countries
Korea, Republic of
Contacts
Public ContactKyeong Jin Kim
Seoul National University of Science and Technology
Outcome results
None listed